Wilmslow Estates Ltd - Net Worth and Insider Trading

Wilmslow Estates Ltd Net Worth

The estimated net worth of Wilmslow Estates Ltd is at least $8,437 dollars as of 2024-05-25. Wilmslow Estates Ltd is the 10% Owner of Ocugen Inc and owns about 4,821 shares of Ocugen Inc (OCGN) stock worth over $8,437. Details can be seen in Wilmslow Estates Ltd's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Wilmslow Estates Ltd has not made any transactions after 2014-12-02 and currently still holds the listed stock(s).

Transaction Summary of Wilmslow Estates Ltd

To

Wilmslow Estates Ltd Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Wilmslow Estates Ltd owns 1 companies in total, including Ocugen Inc (OCGN) .

Click here to see the complete history of Wilmslow Estates Ltd’s form 4 insider trades.

Insider Ownership Summary of Wilmslow Estates Ltd

Ticker Comapny Transaction Date Type of Owner
OCGN Ocugen Inc 2016-09-29 10 percent owner

Wilmslow Estates Ltd Latest Holdings Summary

Wilmslow Estates Ltd currently owns a total of 1 stock. Wilmslow Estates Ltd owns 4,821 shares of Ocugen Inc (OCGN) as of December 2, 2014, with a value of $8,437.

Latest Holdings of Wilmslow Estates Ltd

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
OCGN Ocugen Inc 2014-12-02 4,821 1.75 8,437

Holding Weightings of Wilmslow Estates Ltd


Wilmslow Estates Ltd Form 4 Trading Tracker

According to the SEC Form 4 filings, Wilmslow Estates Ltd has made a total of 0 transactions in Ocugen Inc (OCGN) over the past 5 years. The most-recent trade in Ocugen Inc is the sale of 0 shares on December 2, 2014, which brought Wilmslow Estates Ltd around $0.

Insider Trading History of Wilmslow Estates Ltd

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Wilmslow Estates Ltd Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Wilmslow Estates Ltd Ownership Network

Ownership Network List of Wilmslow Estates Ltd

No Data

Ownership Network Relation of Wilmslow Estates Ltd


Wilmslow Estates Ltd Owned Company Details

What does Ocugen Inc do?

Who are the key executives at Ocugen Inc?

Wilmslow Estates Ltd is the 10 percent owner of Ocugen Inc. Other key executives at Ocugen Inc include CFO/CBO Quan Anh Vu , director & Chief Executive Officer Shankar Musunuri , and Chief Scientific Officer Arun Upadhyay .

Ocugen Inc (OCGN) Insider Trades Summary

Over the past 18 months, Wilmslow Estates Ltd made no insider transaction in Ocugen Inc (OCGN). Other recent insider transactions involving Ocugen Inc (OCGN) include a net sale of 295,809 shares made by Shankar Musunuri , and a net purchase of 200,278 shares made by Junge Zhang .

In summary, during the past 3 months, insiders sold 0 shares of Ocugen Inc (OCGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 295,809 shares of Ocugen Inc (OCGN) were sold and 200,278 shares were bought by its insiders, resulting in a net sale of 95,531 shares.

Ocugen Inc (OCGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Ocugen Inc Insider Transactions

No Available Data

Wilmslow Estates Ltd Mailing Address

Above is the net worth, insider trading, and ownership report for Wilmslow Estates Ltd. You might contact Wilmslow Estates Ltd via mailing address: C/o Histogenics Corporation, 830 Winter Street, Waltham Ma 02451.

Discussions on Wilmslow Estates Ltd

No discussions yet.